SABER .014 PTA Dilatation Catheter 47030300MRecalls & reported problems
Cordis US Corp. · PTA, OTW, 3.0 x 300, 150cm · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 20705032089095), received between Nov 17, 2023 and May 6, 2025 — classified as 2 malfunctions.
The most frequently reported specific device problem is “Detachment of Device or Device Component” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Detachment of Device or Device Component1
- Leak/Splash1
- Material Frayed1
- Material Split, Cut or Torn1
Patient problems
- No Clinical Signs, Symptoms or Conditions2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionMay 6, 2025Detachment of Device or Device Component; Detachment of Device or Device Component
AS REPORTED, THE BALLOON OF A SABER .014 PTA OTW, 3.0 X 300, 150CM PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) BALLOON CATHETER SEPARATED FROM ITS SHAFT AND RAIL DURING REMOVAL FROM THE PATIENT. A NON-CORDIS SNARE WAS USED TO REMOVE THE SECTION OF BALLOON THAT REMAINED OVER THE UNKNOWN WIRE IN THE PATIENT. THE BALLOON WAS REMOVED SUCCESSFULLY, AND NO HARM WAS CAUSED TO THE PATIENT. A CONTRALATERAL APPROACH WAS USED. THE TARGET SITE VESSEL WAS CALCIFIED, NO TORTUOSITY, NO ACUTE OR BIFURCATING ANGLE. THE VESSEL CHARACTERISTICS ACCESSING TARGET SITE HAD NO CALCIFICATION, TORTUOSITY, NO ACUTE OR BIFURCATING ANGLE. THERE WAS NO DIFFICULTY REMOVING THE PROTECTIVE BALLOON COVER. THERE WAS NO DIFFICULTY REMOVING ANY OF THE STERILE PACKAGING COMPONENTS. THE DEVICE MAINTAINED NEGATIVE PRESSURE DURING PREPARATION. THE DEVICE WAS NOT PUT INTO AN ACUTE BEND AT ANY POINT DURING THE PROCEDURE. THE DEVICE WAS ABLE TO CROSS THE LESION, HOWEVER WAS CAUGHT IN IT. THE BALLOON COULD HAVE POTENTIALLY BEEN CAUGHT IN A DEPLOYED STENT, AS THE SECTION OF THE BALLOON THAT BECAME SEPARATED WAS FOUND DISTAL TO AN EXISTING STENT. THE DEVICE DID NOT KINK AT ANY TIME DURING THE PROCEDURE. THERE WERE NO ANOMALIES
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 21971889 ↗MalfunctionNov 17, 2023Material Frayed; Leak/Splash; Material Split, Cut or Torn; Material Frayed; Leak/Splash; Material Split, Cut or Torn
AS REPORTED, THE 3X300 SABER .014 BALLOON EXTENDS SIGNIFICANTLY PAST THE PROXIMAL MAKERS AND SEEM TO MOVE, OR ¿DANCE¿, WITH INCREASING PRESSURE APPLIED. THE DEVICE WAS REMOVED FROM THE PATIENT INTACT. THE CASE WAS COMPLETED WITH A NEW 3X300 SABER .014 BALLOON. THERE WAS NO REPORTED INJURY TO THE PATIENT. THE PRODUCT WAS STORED PROPERLY ACCORDING TO THE INSTRUCTIONS FOR USE (IFU). THERE WAS NO DIFFICULTY REMOVING THE DEVICE FROM THE HOOP, REMOVING THE PROTECTIVE BALLOON COVER, STYLET, OR ANY OF THE STERILE PACKAGING COMPONENTS. THERE WERE NO KINKS OR OTHER DAMAGES NOTED PRIOR TO INSERTING THE PRODUCT INTO THE PATIENT. THE DEVICE WAS PREPPED NORMALLY AND WAS ABLE TO MAINTAIN NEGATIVE PRESSURE. THERE WAS NO RESISTANCE/FRICTION WHILE INSERTING THE BALLOON THROUGH THE ROTATING HEMOSTATIC VALVE. THERE WAS NO RESISTANCE/FRICTION WHILE INSERTING THE BALLOON THROUGH THE GUIDE CATHETER. THE CATHETER WAS NEVER IN AN ACUTE BEND AND WAS NEVER KINKED DURING USE. THERE WAS NO DIFFICULTY ADVANCING THE BALLOON CATHETER THROUGH THE VESSEL. THERE WAS NO DIFFICULTY CROSSING THE LESION. THE LESION WAS IN THE TIBIAL ARTERY. THE LESION WAS NOTED TO HAVE MINIMAL CALCIFICATION. THE VESSEL DID NOT HAVE ANY
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18160851 ↗
Other Catheter, angioplasty, peripheral, transluminal devices
- Coyote™ ES H74939135152010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal879 reports
- Coyote™ ES H74939135204010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal585 reports
- Coyote™ ES H74939135202010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal437 reports
- Coyote™ ES H74939135304010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal384 reports
- Coyote™ ES H74939135404010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal293 reports
- Coyote™ ES H74939134152010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal279 reports
- Coyote™ H74939185202210Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal200 reports
- Coyote™ ES H74939135254010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal127 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page